Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases.

Expert Review of Proteomics
Carlo RodolfoGian Maria Fimia

Abstract

Alzheimer's, Parkinson's and Huntington's disease, and amyotrophic lateral sclerosis are the most relevant neurodegenerative syndromes worldwide. The identification of the etiology and additional factors contributing to the onset and progression of these diseases is of great importance in order to develop both preventive and therapeutic intervention. A common feature of these pathologies is the formation of aggregates, containing mutated and/or misfolded proteins, in specific subsets of neurons, which progressively undergo functional impairment and die. The relationship between protein aggregation and the molecular events leading to neurodegeneration has not yet been clarified. In the last decade, several lines of evidence pointed to a major role for mitochondrial dysfunction in the onset of these pathologies. Here, we review how proteomics has been applied to neurodegenerative diseases in order to characterize the relationship existing between protein aggregation and mitochondrial alterations. Moreover, we highlight recent advances in the use of proteomics to identify protein modifications caused by oxidative stress. Future developments in this field are expected to significantly contribute to the full comprehension of the mol...Continue Reading

References

Sep 1, 1984·Journal of Neuropathology and Experimental Neurology·A HiranoI Nakano
Sep 1, 1984·Journal of Neuropathology and Experimental Neurology·A HiranoG Saccomanno
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·F J StaalL A Herzenberg
Jul 11, 1996·Nature·M A SmithN Kowall
Mar 1, 1996·Journal of Neuropathology and Experimental Neurology·L S Forno
Dec 1, 1996·Neurology·P Jenner, C W Olanow
May 1, 1997·Journal of Neuropathology and Experimental Neurology·H D DurhamD A Figlewicz
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Jul 2, 1998·Journal of Neurochemistry·S E BrowneM F Beal
Mar 31, 1999·Trends in Biochemical Sciences·M F Perutz
Jul 15, 1999·Nature Biotechnology·A J LinkJ R Yates
Oct 28, 1999·Acta Neurologica Scandinavica·T EkegrenS M Aquilonius
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·A WyttenbachD C Rubinsztein
May 10, 2000·Nature Medicine·G Kroemer, J C Reed
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·J A JohnstonR R Kopito
Oct 26, 2000·Trends in Biochemical Sciences·S Raha, B H Robinson
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·P PasinelliD W Cleveland
Dec 21, 2000·Trends in Cell Biology·R R Kopito

❮ Previous
Next ❯

Citations

Jun 2, 2011·Cold Spring Harbor Perspectives in Biology·Michael J BakerThomas Langer
Dec 11, 2013·Molecular Neurobiology·Ramavati PalSimon Geir Møller
Feb 12, 2015·Translational Neurodegeneration·Ru-Jing RenAllan I Levey
Jan 19, 2011·Journal of Proteomics·Angelo D'AlessandroLello Zolla
Nov 28, 2013·Biochimica Et Biophysica Acta·Silvia CampelloFrancesco Cecconi
Dec 7, 2011·Biochimica Et Biophysica Acta·John E MorleyVijaya B Kumar
Jul 23, 2016·Mitochondrion·Johan Palmfeldt, Peter Bross
Oct 30, 2016·International Journal of Biological Macromolecules·Romana ParveenSadaf Fatima
Jan 1, 2014·Rare Diseases·Adriana S TrujilloGirish C Melkani
Aug 12, 2017·Neurochemistry International·Carlo RodolfoFrancesco Cecconi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Related Papers

Cellular and Molecular Life Sciences : CMLS
Dong-Hyung ChoStuart A Lipton
Biochimica Et Biophysica Acta
Paula I MoreiraMark A Smith
© 2021 Meta ULC. All rights reserved